LFWD

SEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · derivative · entry 3

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 25,000 shares

Expires 2025-09-25

F3 · price: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

F3 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

SEC source: 0001628280-17-009767 · wf-form4_150732524690167.xml · derivative · entry 2

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,657 shares

Expires 2024-12-15

F2 · price: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

SEC source: 0001628280-17-009766 · wf-form4_150732523028604.xml · derivative · entry 4

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares, par value NIS 0.01 per share · 17,950 shares

Expires 2026-05-18

F4 · price: Represents stock options granted under the 2014 Plan on May 18, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One-fourth of the cancelled stock options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

F4 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 18, 2016. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. One-fourth of the cancelled stock options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-009766 · wf-form4_150732523028604.xml · derivative · entry 3

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 21,416 shares

Expires 2025-09-25

F3 · price: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

F3 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on September 25, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

SEC source: 0001628280-17-009766 · wf-form4_150732523028604.xml · derivative · entry 2

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,657 shares

Expires 2024-12-15

F2 · price: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant.

SEC source: 0001628280-17-009375 · wf-form4_150576560008222.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 66,280

F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, September 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person.

F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date.

SEC source: 0001628280-17-008933 · wf-form4_150395122213038.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 66,893

F1 · shares: Represents Ordinary Shares sold in the open market on August 28, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on August 24, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-006994 · wf-form4_149976990914650.xml · nonDerivative · entry 1

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 20,281

F1 · shares: Represents Ordinary Shares sold in the open market on July 10, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on July 9, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on January 9, 2016, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter.

SEC source: 0001144204-17-034636 · v469916_4.xml · nonDerivative · entry 2

SCP Vitalife Partners (Israel) II, L.P. · CIK 0001602484 · 10% owner

SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner

SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner

CHURCHILL WINSTON J · CIK 0000923792 · 10% owner

LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,900

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.

SEC source: 0001144204-17-034631 · v469912_4.xml · nonDerivative · entry 2

SCP Vitalife Partners II LP · CIK 0001398330 · 10% owner

SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner

SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner

CHURCHILL WINSTON J · CIK 0000923792 · 10% owner

LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,017,674

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.

SEC source: 0001144204-17-034723 · v469957_form4.xml · nonDerivative · entry 2

Weisman Wayne · CIK 0001602327 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By partnership

Disclosed balance after: 1,500,100

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F4 · shares: The disposed of securities consist of 37,459 Ordinary Shares sold by SCP Vitalife and 12,511 shares sold by SCP Vitalife Israel.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.

F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.

F6 · ownership.nature: As of June 27, 2017, SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,357,574 Ordinary Shares, which consist of 1,017,674 and 339,900 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,500,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (7) to this Form 4.

F7 · ownership.nature: As of June 27, 2017, consists of 1,357,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM", and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the "Vitalife I Entities") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel ("OCS"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities.

SEC source: 0001144204-17-034725 · v469958_form4.xml · nonDerivative · entry 2

Dykan Jeff · CIK 0001661229 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By partnership

Disclosed balance after: 1,500,100

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F4 · shares: The disposed of securities consist of 37,459 Ordinary Shares sold by SCP Vitalife and 12,511 shares sold by SCP Vitalife Israel.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.

F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.

F6 · ownership.nature: As of June 27, 2017, SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,357,574 Ordinary Shares, which consist of 1,017,674 and 339,900 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,500,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (7) to this Form 4.

F7 · ownership.nature: As of June 27, 2017, consists of 1,357,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM", and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the "Vitalife I Entities") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel ("OCS"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities.

SEC source: 0001628280-17-006805 · wf-form4_149874186104195.xml · derivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006801 · wf-form4_149874130276154.xml · derivative · entry 1

Wehrly Peter · CIK 0001671826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006789 · wf-form4_149873835507102.xml · derivative · entry 1

Weisman Wayne · CIK 0001602327 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006799 · wf-form4_149874066278058.xml · derivative · entry 1

PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006795 · wf-form4_149874004579003.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Ordinary Shares, par value NIS 0.01 per share · 125,000 shares

Expires 2027-06-27

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on June 27, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-006795 · wf-form4_149874004579003.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 67,306

F1 · shares: Represents 20,000 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on June 27, 2017. The RSUs vest in four equal yearly installments following the date of the grant. The RSUs may only be settled in Ordinary Shares.

SEC source: 0001628280-17-006814 · wf-form4a_149875831267137.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Ordinary Shares, par value NIS 0.01 per share · 125,000 shares

Expires 2027-06-27

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on June 27, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-006814 · wf-form4a_149875831267137.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 67,306

F1 · shares: Represents 25,000 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on June 27, 2017. The RSUs vest in four equal yearly installments following the date of the grant. The RSUs may only be settled in Ordinary Shares.

SEC source: 0001628280-17-006803 · wf-form4_149874159398415.xml · derivative · entry 1

Dan Aryeh · CIK 0001661255 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006797 · wf-form4_149874017052740.xml · derivative · entry 1

Dykan Jeff · CIK 0001661229 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006793 · wf-form4_149873930241957.xml · derivative · entry 1

Ichiki Yasushi · CIK 0001661271 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001628280-17-006791 · wf-form4_149873860066032.xml · derivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

SEC source: 0001144204-17-034636 · v469916_4.xml · nonDerivative · entry 1

SCP Vitalife Partners (Israel) II, L.P. · CIK 0001602484 · 10% owner

SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner

SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner

CHURCHILL WINSTON J · CIK 0000923792 · 10% owner

LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,411

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.

SEC source: 0001144204-17-034631 · v469912_4.xml · nonDerivative · entry 1

SCP Vitalife Partners II LP · CIK 0001398330 · 10% owner

SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner

SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner

CHURCHILL WINSTON J · CIK 0000923792 · 10% owner

LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,055,133

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.

SEC source: 0001144204-17-034723 · v469957_form4.xml · nonDerivative · entry 1

Weisman Wayne · CIK 0001602327 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By partnership

Disclosed balance after: 1,550,070

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F2 · shares: The disposed of securities consist of 27,759 Ordinary Shares sold by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and 9,271 shares sold by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Israel").

F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.

SEC source: 0001144204-17-034725 · v469958_form4.xml · nonDerivative · entry 1

Dykan Jeff · CIK 0001661229 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By partnership

Disclosed balance after: 1,550,070

F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.

F2 · shares: The disposed of securities consist of 27,759 Ordinary Shares sold by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and 9,271 shares sold by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Israel").

F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.

SEC source: 0001628280-17-006530 · wf-form4_149763999959424.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 42,306

F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, June 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person.

F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date.

SEC source: 0001628280-17-006020 · wf-form4_149617519157956.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 42,918

F1 · shares: Represents Ordinary Shares sold in the open market on May 30, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 24, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-005769 · wf-form4_149548382761247.xml · nonDerivative · entry 1

Hershberger Kevin · CIK 0001580316 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 33,670

F1 · shares: Represents Ordinary Shares sold in the open market on May 22, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 18, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 18, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in three equal yearly installments thereafter.

SEC source: 0001628280-17-005771 · wf-form4_149548387871019.xml · nonDerivative · entry 1

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 20,399

F1 · shares: Represents Ordinary Shares sold in the open market on May 22, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 18, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 18, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in three equal yearly installments thereafter.

SEC source: 0001628280-17-003971 · wf-form4_149270530682452.xml · derivative · entry 2

Hershberger Kevin · CIK 0001580316 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,500

Underlying: Ordinary Shares, par value NIS 0.01 per share · 103,500 shares

Expires 2027-04-18

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on April 18, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-003971 · wf-form4_149270530682452.xml · nonDerivative · entry 1

Hershberger Kevin · CIK 0001580316 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 34,650

F1 · shares: Represents 19,250 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on April 18, 2017. The RSUs vest in four equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares.

SEC source: 0001628280-17-003973 · wf-form4_149270544575782.xml · derivative · entry 2

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Ordinary Shares, par value NIS 0.01 per share · 75,000 shares

Expires 2027-04-18

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on April 18, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-003973 · wf-form4_149270544575782.xml · nonDerivative · entry 1

Gricci Jodi · CIK 0001661235 · VP Global Marketing & Training

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 20,665

F1 · shares: Represents 15,000 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on April 18, 2017. The RSUs vest in four equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares.

SEC source: 0001628280-17-003970 · wf-form4_149270517795322.xml · derivative · entry 2

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Ordinary Shares, par value NIS 0.01 per share · 37,500 shares

Expires 2027-04-18

F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on April 18, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter.

SEC source: 0001628280-17-003970 · wf-form4_149270517795322.xml · nonDerivative · entry 1

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 13,565

F1 · shares: Represents 7,500 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on April 18, 2017. The RSUs vest in four equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares.

SEC source: 0001628280-17-002704 · wf-form4_149000971993122.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 44,700

F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Wedensday, March 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person.

F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date.

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · derivative · entry 6

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,310

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,720 shares

Expires 2023-07-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014.

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 4

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 6,065

F2 · kind: Represents an open market sell effected pusuant to a 10B5-1 plan

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 3

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 10,785

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014.

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · derivative · entry 5

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,030

Underlying: Ordinary Shares, par value NIS 0.01 per share · 500 shares

Expires 2023-07-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014.

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 2

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 6,065

F2 · kind: Represents an open market sell effected pusuant to a 10B5-1 plan

SEC source: 0001628280-17-003090 · wf-form4_149088399318915.xml · nonDerivative · entry 1

Koren Ofir · CIK 0001661277 · Snr VP, R&D and Regulatory

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 6,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014.

SEC source: 0001607962-16-000026 · wf-form4_148192573893065.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 45,322

F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, December 15, 2016 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person.

F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date.

SEC source: 0001607962-16-000018 · wf-form4_147402001802531.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 45,918

F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, September 15, 2016 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person.

F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date.